Company Filing History:
Years Active: 2013
Title: Céline Nicolazzi: Innovator in Biopharmaceuticals
Introduction
Céline Nicolazzi is a prominent inventor based in Paris, France. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on modified soluble FGF receptor Fc fusions. His research has the potential to enhance therapeutic applications in various medical fields.
Latest Patents
Céline Nicolazzi holds one patent for his invention titled "Modified soluble FGF receptor Fc fusions method." This invention relates to modified soluble FGF receptor Fc fusions that comprise a fusion of a soluble fragment or domain of the FGF receptor part with an Fc region of an immunoglobulin part. The invention boasts improved biological activity, including antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) activities. It also includes compositions containing these fusions and methods for producing such modified soluble FGF receptor Fc fusion molecules.
Career Highlights
Céline Nicolazzi is associated with Aventis Pharma S.A., where he has been instrumental in advancing research and development in biopharmaceuticals. His work has contributed to the understanding and application of FGF receptor fusions in therapeutic contexts.
Collaborations
Céline has collaborated with notable colleagues, including Francis Blanche and Béatrice Cameron. Their combined expertise has fostered a productive research environment, leading to innovative solutions in the biopharmaceutical sector.
Conclusion
Céline Nicolazzi's contributions to the field of biopharmaceuticals through his patented inventions highlight his role as a key innovator. His work continues to influence advancements in medical therapies, showcasing the importance of innovation in healthcare.